← Ebola Watch

Congo Ebola Deaths Surge as Vaccine Questions Loom (August 25, 2026)

August 25, 2026 · 3m 57s · Listen

Congo’s surge in Ebola deaths is putting the gap between vaccine promises and protection on the ground under a harsher spotlight. If you’re joining us mid-story, here’s the short version: the DRC Bundibugyo outbreak was already a cross-border concern after WHO warned of a high risk of further spread. Officials launched “Congo River Without Ebola,” a three-month effort to stop transmission moving along the river corridor toward Mbandaka, Kinshasa, and neighboring countries, with port surveillance, early-warning networks, isolation capacity, and mobile floating laboratories. This is Ebola Watch. Today: a weekly death toll that raises the stakes, and vaccines for frontline workers that still haven’t rolled out. Here's Netscape News:

More than 300 people died of Ebola in eastern Congo in the past week, one of the highest weekly tolls yet, government data showed Monday, as health workers struggle to catch up with an outbreak that is spreading at unprecedented speed. Ministry of Health data showed that as of Saturday, the outbreak had recorded 5,514 cases and 2,642 deaths, including 317 deaths reported in the previous seven days.

Three hundred seventeen deaths in seven days. Against the ministry’s total of 2,642 deaths, that’s about 12 percent of the entire recorded death toll in one week. The outbreak is losing people faster than the response is finding them. The key detail is where people are dying: outside treatment centers. In Ituri, most new cases are coming from outside monitored contacts. Those deaths point to missed transmission chains, not simply how severe Ebola is once someone reaches care. The focus in the DRC Bundibugyo outbreak has shifted from river-corridor prevention to 317 deaths in a week. If your family is in or traveling through Ituri, “outside monitored contacts” means health teams often don’t know a household has been exposed until someone is already very sick. The ministry’s 5,514 reported cases and 2,642 deaths imply a 47.9 percent fatality rate. But that’s a blended figure: it depends on which cases have been detected and how suspected cases are classified. North Kivu’s reported rate, 68.6 percent, is a warning about access—not a clean comparison of the virus itself. Friday, Congo received more than 16,000 Ervebo doses, and there’s still no rollout date for frontline workers. “Received” is a warehouse word; a nurse in Ituri needs “administered.” And Ervebo was designed for a different Ebola type. WHO says lab and animal data suggest it may offer some protection against Bundibugyo, but we don’t yet know whether it does—so both the trial and the delivery plan matter. If your team needs a daily briefing on your competitors, market, or beat, Lantern can make a private version like this for your team’s podcast feed. Learn more at lantern podcasts dot com slash briefings, with a 14-day free trial.

We’re watching to see whether Congolese officials announce a rollout schedule for the more than 16,000 Ervebo doses received Friday for frontline workers.

Links to every story are in the show notes, so you can dig into the ones you want to explore further. That’s Ebola Watch for today. This is a Lantern Podcast.